1 – 9 of 9
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Adjuvant imatinib for GIST : duration likely matters
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
(
- Contribution to journal › Article
-
Mark
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
(
- Contribution to journal › Scientific review
- 2018
-
Mark
The management and survival outcomes of nasopharyngeal cancer in the Nordic countries*
(
- Contribution to journal › Article
-
Mark
Bone sarcomas : ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
(
- Contribution to journal › Article
-
Mark
Gastrointestinal stromal tumours : ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
(
- Contribution to journal › Article
- 2012
-
Mark
Adjuvant therapy in primary GIST: state-of-the-art
(
- Contribution to journal › Scientific review
- 2005
-
Mark
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells
(
- Contribution to journal › Article
- 2004
-
Mark
Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel
(
- Contribution to journal › Article